IDEAS home Printed from https://ideas.repec.org/a/bdz/joimer/v3y2024i4p7-12.html

Management Strategies for Mixed GH and Prolactin-Secreting Macroadenomas Following Surgical Failure: A Case Report

Author

Listed:
  • Yosra HASNI

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Sawsen NOUIRA

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Hamza EL FEKIH

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Maissa THABET

    (Department of Interne Medicine, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Wiem SSAFI

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Nawres THABET

    (Ear Nose and Throat Department, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Imen HALLOUL

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Ghada SAAD

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

  • Amel MAAROUFI

    (Department of Endocrinology and Diabetology, Farhat Hached University Hospital, Sousse; Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia)

Abstract

Introduction: Acromegaly is a rare endocrine disorder characterized by excessive growth hormone (GH) production, leading to various complications. The primary treatment goal is to reduce GH and IGF-I levels, with options including surgical resection, medical therapy (e.g., somatostatin receptor ligands (SRLs), dopamine agonists, and pegvisomant), and radiotherapy. The rate of biochemical control reported varies widely across different studies. Case Presentation: A 28-year-old woman with clinically evident acromegaly, characterized by physical changes, was referred due to symptoms including snoring, dental spacing, profuse sweating, joint aches, headaches, visual blurring, and amenorrhea. She had no hypertension, galactorrhea, or diabetes mellitus. Clinical examination revealed a clear acromegalic phenotype and a thyroid goiter. Initial tests showed elevated IGF-1(687 µg/L), high prolactin (165 ng/ml), normal glucose tolerance, and normal lipid profile. MRI identified a large hyperintense mass with supra- and latero-sellar extension. Campimetry revealed a bitemporal hemianopsia in both the right and left eyes. The patient underwent transsphenoidal surgery, with histology confirming a GH/PRL adenoma. At 3 months, residual tumor was still present, and IGF-1 levels were elevated. The treatment with cabergoline and lanreotide for four years did not achieve biological or tumor control of the tumor residue, despite dosage increases. However, switching to pasireotide led to the normalization of IGF-1 levels after four months, although this was accompanied by an increase in fasting blood glucose levels. Conclusion: In summary, this case highlights the effective use of pasireotide, in combination with the dopamine agonist cabergoline, for managing acromegaly in a patient with residual disease. It underscores the importance of personalized treatment plans and the necessity for ongoing monitoring and therapy adjustments to achieve the best possible outcomes.

Suggested Citation

  • Yosra HASNI & Sawsen NOUIRA & Hamza EL FEKIH & Maissa THABET & Wiem SSAFI & Nawres THABET & Imen HALLOUL & Ghada SAAD & Amel MAAROUFI, 2024. "Management Strategies for Mixed GH and Prolactin-Secreting Macroadenomas Following Surgical Failure: A Case Report," Journal of Innovations in Medical Research, Paradigm Academic Press, vol. 3(4), pages 7-12, December.
  • Handle: RePEc:bdz:joimer:v:3:y:2024:i:4:p:7-12
    DOI: 10.56397/JIMR/2024.12.02
    as

    Download full text from publisher

    File URL: https://www.paradigmpress.org/jimr/article/view/1382/1216
    Download Restriction: no

    File URL: https://libkey.io/10.56397/JIMR/2024.12.02?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bdz:joimer:v:3:y:2024:i:4:p:7-12. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Editorial Office (email available below). General contact details of provider: https://www.paradigmpress.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.